Industry Should ‘Lead From The Outside’ With US FDA Policy Staff Decimated, Woodcock Says

 
• By Derrick Gingery
  
External groups can lead on drug development policy, Janet Woodcock said. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from United States